These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21345164)

  • 1. Oxidative stress impairs endothelial nitric oxide levels in Behçets' disease.
    Onur E; Kabaroglu C; Inanir I; Var A; Guvenc Y; Gunay O; Gunduz K
    Cutan Ocul Toxicol; 2011 Sep; 30(3):217-20. PubMed ID: 21345164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
    Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
    Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nitrosative and oxidative stress in Behçet disease.
    Bekpinar S; Kiliç N; Unlüçerçi Y; Akdag-Köse A; Azizlerli G; Ozbek-Kir Z
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):167-71. PubMed ID: 15752284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin levels in Behçet's disease.
    Kandi B; Cicek D; Ilhan N
    J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.
    Acikgoz N; Ermiş N; Yağmur J; Cansel M; Karincaoğlu Y; Ataş H; Cuglan B; Barutcu I; Pekdemir H; Özdemir R
    Angiology; 2011 May; 62(4):296-300. PubMed ID: 20947865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum oxidant/antioxidant status in patients with Behçet's disease.
    Taysi S; Kocer I; Memisogullari R; Kiziltunc A
    Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum carbonyl and malondialdehyde levels following colchicine and vitamin E treatment in Behcet's disease.
    Gulbahar O; Adisen H; Koca C; Aricioglu A; Gulekon A
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):521-4. PubMed ID: 18040527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease.
    Aydin E; Sögüt S; Ozyurt H; Ozugurlu F; Akyol O
    Ophthalmic Res; 2004; 36(3):177-82. PubMed ID: 15103210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum paraoxonase activity is decreased in the active stage of Behçet's disease.
    Karakucuk S; Baskol G; Oner AO; Baskol M; Mirza E; Ustdal M
    Br J Ophthalmol; 2004 Oct; 88(10):1256-8. PubMed ID: 15377545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
    Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
    Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma.
    Erdurmuş M; Yağcı R; Atış Ö; Karadağ R; Akbaş A; Hepşen IF
    Curr Eye Res; 2011 Aug; 36(8):713-8. PubMed ID: 21780920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
    Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
    Harzallah O; Kerkeni A; Baati T; Mahjoub S
    Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of free fatty acids on nitric oxide synthase activity and mRNA expression in endothelial cell of SD rat aorta].
    Yu YR; Li HL; Zhang XX
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):193-6. PubMed ID: 18630681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plasma from patients with Behçet's disease on the production of nitric oxide in cultured human umbilical vein endothelial cells.
    Orem A; Ertürk M; Cimşit G; Kural BV
    Med Princ Pract; 2004; 13(1):35-8. PubMed ID: 14657617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sister chromatid exchange and micronucleus studies in patients with Behçet's disease.
    Karaman A; Kadi M; Kara F
    J Cutan Pathol; 2009 Aug; 36(8):831-7. PubMed ID: 19159395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.